The last year has been a hugely exiting time for pharma with the industry continuing to take center stage globally with record levels of innovation and the successful rollout of COVID vaccines and boosters. But looking a little further ahead, areas like the use of mRNA outside of COVID vaccines could potentially bring in a new wave of potential opportunities in the drug device and delivery space. Smart packaging innovations are also generating excitement, environmental advancements have seen an accelerated rate of adoption, and new ground is being broken daily.
Pharmapack Europe is an integral part of the industry’s efforts to harness the power of networking, knowledge sharing, and partnering—the underpinnings of innovation that will drive growth in the years ahead. The event will provide a window into the partnering of today, as well ground-breaking innovations yet to hit the market.
The 2022 edition will take place as a Smart Event, with a hybrid experience that extends the value of Pharmapack beyond the two days in Paris. For one week before and one week after the in-person event, all attendees, speakers, and exhibitors will have access to the on-line platform where they can plan their on-site experience by viewing exhibitor profiles and product information, while also marking out the sessions they want to attend.
Pharmapack Europe 2022’s Smart Event will take place on-line May 9-27, with the first week dedicated to on-line learning labs and interactive matching, as well the in-person event at Paris Expo, Porte de Versailles, Paris on May 18 and 19, and a week afterwards to catch up on any missed sessions or meetings.
Pharmapack Europe 2022 will host more than 50 sessions (on-line and in-person). Learning Labs will be hosted on-site and digitally, and new innovations will be showcased through the Start-up Hub and Innovation Gallery. The two-day in-person event will feature networking with 300+ exhibitors covering the pharma packaging and drug delivery industry, and live conference sessions covering three tracks.
The Design & Development Track will feature insights from device guru, Thomas Watts, engineering consultant at Team Consulting, who explores the Challenges of Cloud Connectivity. In particular, he will discuss how innovators can avoid many of the common pitfalls faced when integrating connectivity into novel devices.
Two hot areas likely to significantly impact all industry thinking in the next year are how to make packaging both more eco and user-friendly. Eco design analysis will be provided by speaker Romane Osadnick—key account manager, Adelphe—as he explores how to comply with regulatory requirements for the application of Eco-Design in Pharmaceutical Packaging. From the consumer sector’s perspective, Clare Beddoes, senior insights research consultant, Cambridge Design Partnership, and Ben Kubler, consultant industrial designer, Cambridge Design Partnership, will breakdown the current landscape on how Drug Delivery is Evolving the User Experience.
In contrast, the highly anticipated second track will delve into the defining challenge of the next decade, exploring sustainability implications for devices and packaging. Tom Oakley, director of drug delivery device development, Springboard, will speak on the Strategies for Environmental Sustainability—looking in particular at the transition we are seeing to sustainability being seen as a primary concern for the drug delivery device industry.
Another environmental concern gaining increased traction is the medical waste generated at healthcare facilities. Most excitingly, new innovations are now helping to overcome this challenge. Mayur Patel, digital health expert, PA Consulting, will explore the Duality of Safety and Efficacy in Green Drug Delivery. His session will demonstrate how your company can join others leading “the economy of the future” by focusing on minimizing waste and maximizing resources through reuse, distribution, and recycling.
The third track is entitled, Combination Products & Biologics, with four sessions featuring topics on packaging materials and regulations. One eagerly anticipated area is the future impact of mRNA technologies after the ground-breaking success of the two COVID vaccines. Tom Van Ginneken, head of product management polymer solutions, SCHOTT AG, will discuss the Long-Term Effects of mRNA Delivery, exploring the packaging considerations of such low-temperature products.
In his insightful session on regulatory strategies, Fabien Roy, partner, Hogan Lovells International LLP, will review the process, and considerations, of registering innovations so that they clear regulatory review and approval smoothly.
Also in Track 3, Asmita Khanolkar, senior director, Cambridge Pharma, SMC, will discuss integrated approaches for the rapid development of novel therapies and the Dynamics and Outlook on High-Volume Subcutaneous Drug Delivery. Peter J. Schmitt, managing director & co-founder of Montesino, will discuss The Limitations of Incumbent Materials, exploring the intertwined challenges of extractables and leachables, and whether incumbent materials can meet the challenge or if it is time they are replaced by engineering-grade polymers.
The eponymous Pharmapack Awards will be hosted across two categories: Exhibitor and Health Product. The awards ceremony will take place digitally at 16:00 CET on May 17, and on-site at the exhibitor party on May 18.